Publication date: Aug 02, 2024 This study explores a retrospective non-targeted analysis (NTA), based on Ultra High-Performance Liquid Chromatography coupled to High-Resolution Mass Spectrometry (UHPLC-HRMS), to assess hidden chemicals of ... Read more

Publication date: Sep 06, 2024 This study aimed to evaluate the effectiveness of COVID-19 vaccines in preventing COVID-19 outcomes when the Omicron variant was predominant in Aotearoa New Zealand. We ... Read more

Publication date: Sep 04, 2024 The severity of COVID-19 outbreaks is disproportionate across settings (e. g., long-term care facilities (LTCF), schools) across Canada. Few studies have examined factors associated with ... Read more

Publication date: Aug 30, 2024 The ongoing coronavirus disease 2019 (COVID-19) pandemic presents serious public health threats. Omicron, the current most prevalent strain of COVID-19, has a low fatality rate ... Read more

Publication date: Aug 30, 2024 The ongoing coronavirus disease 2019 (COVID-19) pandemic presents serious public health threats. Omicron, the current most prevalent strain of COVID-19, has a low fatality rate ... Read more

Publication date: Aug 30, 2024 The ongoing coronavirus disease 2019 (COVID-19) pandemic presents serious public health threats. Omicron, the current most prevalent strain of COVID-19, has a low fatality rate ... Read more

Publication date: Aug 30, 2024 The ongoing coronavirus disease 2019 (COVID-19) pandemic presents serious public health threats. Omicron, the current most prevalent strain of COVID-19, has a low fatality rate ... Read more

Publication date: Aug 30, 2024 The optimal timing of tocilizumab treatment during the disease course of COVID-19 has yet to be adequately defined in the context of randomised controlled trials ... Read more

Publication date: Aug 30, 2024 The optimal timing of tocilizumab treatment during the disease course of COVID-19 has yet to be adequately defined in the context of randomised controlled trials ... Read more

Publication date: Aug 30, 2024 The optimal timing of tocilizumab treatment during the disease course of COVID-19 has yet to be adequately defined in the context of randomised controlled trials ... Read more